Richard Browne Email & Phone Number

I provide all aspects of Market Access to all sizes of pharmaceutical and biotechnology companies. I have worked within market access for over 15yrs, holding many senior roles.I can provide consultancy on a day by day basis, or for specific projects, or covering a specific period of time e.g. maternity leave.I can provide consultancy on (but not exclusively) for the following:Launch strategyPricing strategy HTA project management and submissionsHTA implementationTenders or confidential commercial dealsPatient advocacy Government affairs Management of market access team Account prioritisation and segmentation

Brisbane, Ca, Us

Responsible for the UK, ROI and the Nordics • Delivery of full HTA reimbursement across UK, ROI and the Nordics• Delivery of EAMS scheme for phase III project• Responsible for overarching strategy, pricing, value proposition• PAGs, government affairs and public affairs strategy• New product development, in-field implementation of policies and projects to drive uptake, service enhancement• Full understanding of local and national commissioning• Management of 10 infield market access directors

Stockholm, Stockholm County, Se

Rare Diseases:Led the HTA submission for Familial Mediterranean Fever (FMF)• Project managed dossier submissionCollaboration with Commercial and MedicalWorked with PAGs

Bagsværd, Dk

o Leading the market access strategy and material developmento Defining clear funding routeso Driving uptake post-NICEo Matrix working with Sales and Medicalo Working collaboratively with the infield team to capture insights from HCPs

Paris, France, Fr

Sanofi GenzymeSenior Value and Access Lead (Immunology)In addition to the below:o Member of Atopic Leadership team and Patient Access Leadership team focusing on medium to long term priorities and resourcingo Managing a team to support all new indications and pull through (via pathway strategy) for current licenseo Collaborative working with medical, commercial and globalo Multiple indication pricing to deliver the P&L

Paris, France, Fr

Nov 16 – Jun 18 – Value and Access Lead (Immunology)o Prelaunch strategy for a multiple indication producto Matrix lead -– HEOR, RWE, Price and Reimbursement, In-field team, Patient Advocacy and Government Affairso Building innovative cost effective solutions for new indication including PAS, pricing and reimbursement routes for payers (CCGs and NHSE)o Bringing the outside in - informing the business of the needs of the payero Create value proposition, payer communication strategy and materialso Member of the Employee Forum

North Chicago, Illinois, Us

North Chicago, Illinois, Us

Strategic planning pre and post licenseMarket Access Marketing leadHTA development and support (including external stakeholder strategy and engagement)Patient Access Scheme development and implementation (including process flow and PASLU engagement)Value proposition development and implementation Input into long term medical plans to support value proposition

Market access for speciality medicines, Heath economics, HES/SUS data analysis, NICE implementation.Market Access Marketing lead - project management of oncology and hep c discussion guides, APN development, pre-launch strategy team member and CRM lead

Raritan, New Jersey, Us

Market Access and NICE implementation for high cost drugs. Market expansion for new licences and over coming funding blocks across the South East and South Central SHAs. Using local and national NHS policies along with health econmic models and busines case to drive market penetration.